Brodalumab Subcutaneous and Lenvatinib
Determining the interaction of Brodalumab Subcutaneous and Lenvatinib and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Lenvatinib Mesylate
- Brodalumab Subcutaneous-Lenvima
- Brodalumab Subcutaneous-Lenvima (14 MG Daily Dose)
- Brodalumab Subcutaneous-Lenvima (18 MG Daily Dose)
- Brodalumab Subcutaneous-Lenvima (20 MG Daily Dose)
- Brodalumab Subcutaneous-Lenvima (24 MG Daily Dose)
- Lenvatinib-Brodspec
- Lenvatinib-Brom Mal Phenyl HCl Dex HBr
- Lenvatinib-Bromaline
- Lenvatinib-Bromaline DM
- Lenvatinib-Bromatan Plus
- Lenvatinib-Bromatan-DM